RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1.
Blood
; 134(1): 59-73, 2019 07 04.
Article
in En
| MEDLINE
| ID: mdl-31023702
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Core Binding Factor Alpha 2 Subunit
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Blood
Year:
2019
Type:
Article